Knowledge. Discipline. Expertise.
Our Approach
Tarvos Capital’s principle business focus is on opportunities in the Life Sciences and Healthcare Industry. We are idea driven, looking for novel technologies, products and product candidates that address large unmet needs. We are value conscious and very sensitive to quality of management.
Knowledge is the cornerstone of our investment philosophy. Our approach attempts to capitalize on our core expertise and experience in the medical technology and biotechnology sectors. Our research, analysis and valuation process is designed to identify and avoid overvalued stocks. We take a long-term, structured approach to portfolio management but are sensitive to short-term stock and market dynamics.
Research.
Ideas are sourced from all over but all face a similar rigorous review process. The process leverages our in depth knowledge of industry, markets and product opportunities. This core expertise provides us an opportunity to exploit market inefficiencies created by the complexity of products, markets, regulation and an all too often focus on the short-term outlook.
Analysis.
Translating ideas and opportunities into a common financial language is a key to comparing one idea against the other. Analysis is also important in identifying structural issues of companies and assessing the probability of commercial success and building value for shareholders.
Valuation.
Our goal is to avoid overvalued situations no matter how exciting an opportunity it may seem. This discipline minimizes the emotional influence of the process. It also allows us to reduce risk and maximize returns by creating a more focused, structured portfolio.